Friday, July 10, 2026

pharma · COVID19 · COVID-19 Pandemic

Livzon Pharmaceutical Group

Livzon Pharmaceutical Group clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
1985 Founded
656 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1985
Employees
656
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Programs

Livzon Pharmaceutical Group projects

1 ClinicalTrials.gov programs sponsored by Livzon Pharmaceutical Group.

Livzon Pharmaceutical Group has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Recombinant SARS-CoV-2 Fusion Protein Vaccine

    Livzon Pharmaceutical Group

    COVID19

    phase 1 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Livzon Pharmaceutical Group have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.